SCM

Soleus Capital Management Portfolio holdings

AUM $1.87B
1-Year Est. Return 32.07%
This Quarter Est. Return
1 Year Est. Return
+32.07%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.87B
AUM Growth
+$423M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
113
New
Increased
Reduced
Closed

Top Buys

1
+$61.3M
2
+$57.8M
3
+$45.9M
4
TWST icon
Twist Bioscience
TWST
+$42.5M
5
FOLD icon
Amicus Therapeutics
FOLD
+$37M

Top Sells

1
+$90.5M
2
+$66.8M
3
+$41.7M
4
GRFS icon
Grifois
GRFS
+$32.4M
5
URGN icon
UroGen Pharma
URGN
+$30M

Sector Composition

1 Healthcare 100%
2 Consumer Staples 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IMUX icon
76
Immunic
IMUX
$77.5M
$1.39M 0.07%
1,580,007
-5,713,000
ADVM
77
DELISTED
Adverum Biotechnologies
ADVM
$1.3M 0.07%
287,246
LQDA icon
78
Liquidia Corp
LQDA
$3.42B
$1.14M 0.06%
+50,000
EPIX
79
DELISTED
ESSA Pharma
EPIX
$833K 0.04%
4,362,026
+2,100,000
MYO icon
80
Myomo
MYO
$37.7M
$628K 0.03%
704,275
MREO
81
Mereo BioPharma
MREO
$89.9M
$617K 0.03%
299,711
-300,000
TECX
82
Tectonic Therapeutic
TECX
$357M
$392K 0.02%
25,000
-51,841
INSM icon
83
Insmed
INSM
$34.9B
$367K 0.02%
2,550
-70,222
SEPN
84
Septerna Inc
SEPN
$1.21B
$343K 0.02%
18,260
-57,196
KOD icon
85
Kodiak Sciences
KOD
$1.63B
$322K 0.02%
+19,644
TRVI icon
86
Trevi Therapeutics
TRVI
$1.34B
$229K 0.01%
25,000
-675,000
DCTH icon
87
Delcath Systems
DCTH
$354M
$108K 0.01%
10,000
-15,000
THTX
88
DELISTED
Theratechnologies
THTX
– –
-4,801,376
TNDM icon
89
Tandem Diabetes Care
TNDM
$1.39B
– –
-200,000
WGS icon
90
GeneDx Holdings
WGS
$2.88B
– –
-40,000
ABVX
91
Abivax
ABVX
$9.32B
– –
-125,000
ADPT icon
92
Adaptive Biotechnologies
ADPT
$2.73B
– –
-10,000
ASND icon
93
Ascendis Pharma
ASND
$13.2B
– –
-85,000
AXSM icon
94
Axsome Therapeutics
AXSM
$9.3B
– –
-2,000
BCYC
95
Bicycle Therapeutics
BCYC
$463M
– –
-100,000
CTMX icon
96
CytomX Therapeutics
CTMX
$910M
– –
-1,304,300
DNLI icon
97
Denali Therapeutics
DNLI
$2.74B
– –
-182,110
ENOV icon
98
Enovis
ENOV
$1.32B
– –
-315,000
EWTX icon
99
Edgewise Therapeutics
EWTX
$3.04B
– –
-76,493
HUM icon
100
Humana
HUM
$32.2B
– –
-79,600
1 2 3
4
5